Vaxcyte, Inc. (PCVX) Discusses Top Line Results From OPUS-1 Phase 3 Trial of VAX-31 Pneumococcal Vaccine Candidate – Slideshow

Vaxcyte, Inc. (PCVX) Discusses Top Line Results From OPUS-1 Phase 3 Trial of VAX-31 Pneumococcal Vaccine Candidate – Slideshow#Vaxcyte #PCVX #Discusses #Top #Line #Results #OPUS1 #Phase #Trial #VAX31 #Pneumococcal #Vaccine #Candidate #Slideshow